These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31904280)

  • 1. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN; Heinrich A; Brilloff S; Jarzebska N; Martens-Lobenhoffer J; Bode-Böger SM; Todorov VT; Hugo CPM; Weiss N; Hohenstein B
    Atheroscler Suppl; 2017 Nov; 30():319-325. PubMed ID: 29096857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
    Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
    J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y; Ueda S; Yamagishi S; Matsuguma K; Shibata R; Fukami K; Matsuoka H; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2007 May; 18(5):1525-33. PubMed ID: 17409314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
    Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
    Lu CW; Lin Y; Lei YP; Wang L; He ZM; Xiong Y
    PLoS One; 2017; 12(7):e0179908. PubMed ID: 28715444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
    Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
    Torondel B; Nandi M; Kelly P; Wojciak-Stothard B; Fleming I; Leiper J
    Vasc Med; 2010 Jun; 15(3):205-13. PubMed ID: 20219849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F; Onozato ML; Luo Z; Wilcox CS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V; Tomandl J; Pácal L; Klepárník M; Malúšková D; Bartáková V; Kuricová K; Rehořová J; Stěpánková S; Svojanovský J; Olšovský J; Bělobrádková J; Krusová D; Jurajda M; Mužík J; Pavlík T; Kaňková K
    Kidney Blood Press Res; 2012; 36(1):200-8. PubMed ID: 23147199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
    Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of losartan and pentoxifylline on renal dimethylarginine dimethylaminohydrolase-1 expression in proteinuric nephropathy.
    Park SH; Hyun SH; Ryu HM; Ahn JS; Oh SH; Oh EJ; Yoon SH; Choi JY; Cho JH; Kim CD; Kim YL
    Am J Nephrol; 2013; 37(5):491-500. PubMed ID: 23635662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
    You H; Gao T; Cooper TK; Morris SM; Awad AS
    Kidney Int; 2013 Dec; 84(6):1189-97. PubMed ID: 23760286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.
    Nakayama Y; Ueda S; Yamagishi S; Obara N; Taguchi K; Ando R; Kaida Y; Iwatani R; Kaifu K; Yokoro M; Toyonaga M; Kusumoto T; Fukami K; Okuda S
    Kidney Int; 2014 Mar; 85(3):570-8. PubMed ID: 24107853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.